Genomic Vision SA
PAR:GV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Genomic Vision SA
PAR:GV
|
FR |
|
Y
|
Yongmao Holdings Ltd
SGX:BKX
|
SG |
|
noco-noco Inc
OTC:NCNCF
|
SG |
|
Champion Electric Metals Inc
OTC:CHELF
|
CA |
|
E
|
EPIC Suisse AG
SIX:EPIC
|
CH |
|
Pearl Gull Iron Ltd
ASX:PLG
|
AU |
|
T
|
TrickleStar Ltd
SGX:CYW
|
SG |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GV's stock price target?
Not Available
GV doesn't have any price targets made by Wall Street professionals.
What is Genomic Vision SA's Revenue forecast?
Projected CAGR
19%
For the last 8 years the
compound annual growth rate for
Genomic Vision SA's revenue is
-14%.
The projected
CAGR
for the next 4 years is
19%.